Cargando…
1795. Safety Outcomes of the Use of β-Lactam Therapy in Patients With Documented β-Lactam Allergy
BACKGROUND: In patients with a true penicillin allergy, the reported cross-reactivity to cephalosporin and carbapenem antibiotics are approximately 3% and 1%, respectively. Although true β-lactam allergies are rare, providers are reluctant to challenge patients with other β-lactams, which significan...
Autor principal: | Bjork, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253545/ http://dx.doi.org/10.1093/ofid/ofy210.1451 |
Ejemplares similares
-
1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022) -
994. Effect on Β-lactam Usage Following Implementation of Clinical Pharmacy Services to Improve Β-lactam Allergy History Documentation
por: Harrington, Nicole, et al.
Publicado: (2019) -
1003. Impact of a Standardized Pharmacist-led Β-lactam Allergy Interview on the Quality of Allergy Documentation
por: Nguyen, Cynthia T, et al.
Publicado: (2019) -
β-Lactam Allergy in Children
por: Suleyman, Ayse, et al.
Publicado: (2021) -
Documented β-Lactam Allergy and Risk for Cesarean Surgical Site Infection
por: Johnston, Courtney, et al.
Publicado: (2022)